0001179110-13-015568.txt : 20131016
0001179110-13-015568.hdr.sgml : 20131016
20131016193154
ACCESSION NUMBER: 0001179110-13-015568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131011
FILED AS OF DATE: 20131016
DATE AS OF CHANGE: 20131016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astex Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0000919722
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911841574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4140 DUBLIN BLVD
STREET 2: SUITE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
BUSINESS PHONE: 9255600100
MAIL ADDRESS:
STREET 1: 4140 DUBLIN BLVD
STREET 2: STE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERGEN INC
DATE OF NAME CHANGE: 19960125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buckland Martin
CENTRAL INDEX KEY: 0001525784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27628
FILM NUMBER: 131155040
MAIL ADDRESS:
STREET 1: 436 CAMBRIDGE SCIENCE PARK
STREET 2: MILTON ROAD
CITY: CAMBRIDGE
STATE: X0
ZIP: CB40QA
4
1
edgar.xml
FORM 4 -
X0306
4
2013-10-11
1
0000919722
Astex Pharmaceuticals, Inc
ASTX
0001525784
Buckland Martin
C/O ASTEX PHARMACEUTICALS
436 CAMBRIDGE SCIENCE PARK MILTON ROAD
CAMBRIDGE
X0
CB4 0QA
UNITED KINGDOM
0
1
0
0
Chief Business Officer
Common Stock
2013-10-11
4
U
0
5963
D
0
D
Employee Stock Option (Right to buy)
.70
2013-10-11
4
D
0
52384
D
2011-07-20
2014-09-30
Common Stock
52384
0
D
Employee Stock Option (Right to buy)
0.84
2013-10-11
4
D
0
26192
D
2011-07-20
2015-12-01
Common Stock
26192
0
D
Employee Stock Option (Right to buy)
.87
2013-10-11
4
D
0
19644
D
2011-07-20
2016-12-01
Common Stock
19644
0
D
Employee Stock Option (Right to buy)
.73
2013-10-11
4
D
0
26192
D
2018-06-24
Common Stock
26192
0
D
Employee Stock Option (Right to buy)
.79
2013-10-11
4
D
0
32085
D
2019-06-22
Common Stock
32085
0
D
Employee Stock Option (Right to buy)
.92
2013-10-11
4
D
0
98220
D
2020-05-28
Common Stock
98220
0
D
Employee Stock Option (Right to buy)
2.21
2013-10-11
4
D
0
150000
D
2021-09-16
Common Stock
150000
0
D
Employee Stock Option (Right to buy)
1.89
2013-10-11
4
D
0
180000
D
2022-03-07
Common Stock
180000
0
D
Employee Stock Option (Right to buy)
2.71
2013-10-11
4
D
0
180000
D
2022-12-06
Common Stock
180000
0
D
The number of shares disposed of represents 5,963 shares acquired under the Issuer's 2008 Employee Stock Purchase Plan.
Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co. Ltd., and Autumn Aquisition Corporation (the "Merger Agreement"), each share of Common Stock was exchanged for $8.50 in cash.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $408,595.20, which represents the difference between $8.50 and the exercise price of the option per share.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $200,630,72, which represents the difference between $8.50 and the exercise price of the option per share.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $149,833.72, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/4th of the shares on June 24, 2009 and as to 1/48th of the shares on each one month anniversary thereafter.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $203,511.84, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/4th of the shares on June 22, 2010 and as to 1/48th of the shares on each one month anniversary thereafter.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $247,375.35, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/4th of the shares on May 28, 2011 and as to 1/48th of the shares on each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $744,507.60, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/4th of the shares on September 16, 2012 and as to 1/48th of the shares on each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $943,500.00, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/48th of the shares on April 7, 2012 and each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $1,189,800.00, which represents the difference between $8.50 and the exercise price of the option per share.
The option originally provided for vesting as to 1/48th of the shares on January 6, 2013 and each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $1,042,200.00, which represents the difference between $8.50 and the exercise price of the option per share.
/s/ Martin Buckland
2013-10-16